These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Effect on steroid metabolism of STC-407 and cyproterone acetate in female hirsutism. Mosonyi L, Halmy L, Fehér T, Zöld M. Acta Med Acad Sci Hung; 1973; 30(1):39-47. PubMed ID: 4361464 [No Abstract] [Full Text] [Related]
25. [Serum testosterone determination in the antiandrogen therapy of sexual deviations with cyproterone acetate (preliminary report of experiences)]. Glander HJ, Sorger D. Psychiatr Neurol Med Psychol (Leipz); 1984 Oct; 36(10):596-603. PubMed ID: 6240067 [Abstract] [Full Text] [Related]
26. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA. Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [Abstract] [Full Text] [Related]
27. Effects of cyproterone acetate on adrenal steroidogenesis in vitro. Pham-Huu-Trung MT, de Smitter N, Bogyo A, Girard F. Horm Res; 1984 Aug; 20(2):108-15. PubMed ID: 6237971 [Abstract] [Full Text] [Related]
29. Isolation and identification of 15-beta-hydroxy cyproterone acetate as a new metabolite of cyproterone acetate in dog, monkey and man. Bhargava AS, Seeger A, Günzel P. Steroids; 1977 Sep; 30(3):407-18. PubMed ID: 413211 [Abstract] [Full Text] [Related]
30. Time dependency and reversibility of the effects of exclusive cyproterone acetate therapy on pituitary adrenal function in hirsute women. Salvador J, Barbería JJ, Martí J, Forga L, Saavedra J, Moncada E. Acta Endocrinol (Copenh); 1985 Oct; 110(2):164-9. PubMed ID: 2998129 [Abstract] [Full Text] [Related]
31. NTP Technical Report on the comparative toxicity studies of allyl acetate (CAS No. 591-87-7), allyl alcohol (CAS No. 107-18-6) and acrolein (CAS No. 107-02-8) administered by gavage to F344/N rats and B6C3F1 mice. Irwin RD. Toxic Rep Ser; 2006 Jul; (48):1-73, A1-H10. PubMed ID: 17160105 [Abstract] [Full Text] [Related]
32. Oestrogenic activity of cyproterone acetate in female mice. Lohiya NK, Arya M. Endokrinologie; 1981 Oct; 78(1):21-7. PubMed ID: 6172270 [Abstract] [Full Text] [Related]
33. Adrenocortical function in children with precocious sexual development during treatment with cyproterone acetate. Stivel MS, Kauli R, Kaufman H, Laron Z. Clin Endocrinol (Oxf); 1982 Feb; 16(2):163-9. PubMed ID: 6279337 [Abstract] [Full Text] [Related]
34. Proceedings: Studies on the effects of cyproterone acetate administered in adulthood or in early life on subsequent endocrine function and agonistic behavior in male albino labortory mice. Brain PF, Evans CM, Poole AE. J Endocrinol; 1974 May; 61(2):XLV. PubMed ID: 4857743 [No Abstract] [Full Text] [Related]
35. The effect of cyproterone acetate on adrenal cortical function in children with precocious puberty. Heinze F, Teller WM, Fehm HL, Joos A. Eur J Pediatr; 1978 Jun 20; 128(2):81-8. PubMed ID: 208851 [Abstract] [Full Text] [Related]
36. [Systemic effect of diflucortolone valerate after dermal application (author's transl)]. Wendt H, Reckers R. Arzneimittelforschung; 1976 Jun 20; 26(7b):1509-13. PubMed ID: 188429 [Abstract] [Full Text] [Related]
37. Antiandrogens do not reverse androgen-induced inhibition of sex hormone-binding globulin levels in adult female rhesus monkeys. Winneker RC, Wagner MM, Shaw CJ, Snyder BW. Endocrinology; 1989 Aug 20; 125(2):715-20. PubMed ID: 2526727 [Abstract] [Full Text] [Related]
38. Effects of self-administered cocaine on plasma adrenocorticotropic hormone and cortisol in male rhesus monkeys. Broadbear JH, Winger G, Cicero TJ, Woods JH. J Pharmacol Exp Ther; 1999 Jun 20; 289(3):1641-7. PubMed ID: 10336563 [Abstract] [Full Text] [Related]
39. Effects of cyproterone acetate on growth and androgen metabolism of rat ventral prostate transplants. Thomas JA, Edwards WD, Felice PR. Endocrinol Exp; 1981 Sep 20; 15(3):171-9. PubMed ID: 6457737 [Abstract] [Full Text] [Related]
40. [Studies on the Pharmacology of 6alpha,9-difluoro-11beta-hydroxy-16alpha-methyl-21-valeryloxy-1,4-pregnadiene-3,20-dione (diflucortolon valerate) (author's transl)]. Kapp VJ, Koch H, Casals-Stenzel J, Töpert M, Gerhards E. Arzneimittelforschung; 1976 Sep 20; 26(7b):1463-75. PubMed ID: 188428 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]